Semen endocannabinoids are correlated to sperm quality in a cohort of 200 young Swiss men
- PMID: 32167658
- DOI: 10.1111/andr.12785
Semen endocannabinoids are correlated to sperm quality in a cohort of 200 young Swiss men
Abstract
Background: A role for endocannabinoids in the male and female reproductive systems has been highlighted during the recent decades. Some of these compounds bind the cannabinoid CB1 receptor, which is abundantly expressed in the central nervous system but also present in the reproductive system, while others act as 'entourage compounds' modulators.
Objectives: The present study aimed at evaluating the relationship between sperm quality and endocannabinoid profiles in a cohort of 200 young Swiss men and whether the presence of specific xenobiotics could influence these profiles.
Materials and methods: Semen analysis was performed according to WHO guidelines. Endocannabinoid profiles in blood and semen, as well as bisphenol A and S in urine, were determined by LC-MSMS methods. The presence of selected drugs was tested in urine by immunological screening, and urinary tetrahydrocannabinol (THC) metabolites were quantified by GC-MS.
Results: Anandamide concentrations in seminal fluid and oleoylethanolamide (OEA) concentrations in blood serum appeared inversely correlated with sperm motility, while semen palmytoylethanolamide (PEA) was positively linked to sperm concentration. Moreover, OEA and PEA in seminal fluid were associated with better sperm morphology. Interestingly, the concentrations of the same endocannabinoids measured in both blood and semen were not correlated, and the presence of THC metabolites in some individuals was linked to lower concentrations of endocannabinoids.
Conclusions: In the context of the general decline of the sperm count observed within the male population, endocannabinoids in semen constitute a class of promising biochemical markers that open new perspectives as a complement for the usual evaluation of semen quality or for the toxicological screening of individuals' exposure to putative endocrine disruptors.
Keywords: blood; endocannabinoids; endocrine disruptors; fertility; semen quality; sperm.
© 2020 American Society of Andrology and European Academy of Andrology.
References
REFERENCES
-
- World Health Organisation. WHO laboratory manual for the examination and processing of human semen, 5th edn. Geneva: WHO Press; 2010.
-
- Zegers-Hochschild F, Adamson GD, de Mouzon J, et al. International Committe for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary ART terminology. Fertil Steril. 2009;92:1520-1524.
-
- Nieschlag E, Behre HM, Nieschlag S. Male reproductive health and dysfunction. Asian J Androl. 2012;12(3):458.
-
- Kolodny R, Masters W, Kolodner R, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med. 1974;290(16):872-874.
-
- Payne KS, Mazur DJ, Hotaling JM, Pastuszak AW. Cannabis and male fertility: a sytematic review. J Urol. 2019;674-681.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
